Avanos Medical, Inc.'s latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 6 Aug 2026The company borrowed $675 million and has access to $100 million more, showing it has money to complete its acquisition by American Industrial Partners.
75% of shareholders voted yes on July 22, 2026, clearing the path for the company to be acquired at $25 per share in cash.
Two lawsuits filed June 29-30, 2026 allege the company didn't fully disclose merger details, which could delay or block the deal.
On July 2, 2026, the company got final government clearance, meaning the $25-per-share merger can now close.
Quarterly earnings updates help investors understand company performance as it transitions to new ownership.
Companies release quarterly results so investors can track if the business is growing or shrinking.
On April 13, 2026, the company agreed to be acquired, meaning shareholders will receive $25 cash per share owned.
Stocky reads Avanos Medical, Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Avanos Medical, Inc.'s most recent tracked filing was a 8-K on 30 Jul 2026: Secures $775 million credit facility for merger financing.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.